Bellone S, Roque DM, Siegel ER, Buza N, et al. A phase 2 evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability. Cancer 2021 Dec 7. doi: 10.1002/cncr.34025.
PMID: 34875107